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 Abstract   
Endometriosis is defined as the occurrence of endometrial glands and endometrial stromal cells outside their typi-
cal localization within the uterus. Malignant transformation of endometriosis foci in a scar after a caesarean section 
(cc) is very rare – until 2013 (in a span of 40 years), about 40 such cases have been described. In our article, we 
describe a case of a 42-year-old woman with a tumour localized in a scar after a caesarean section. The tumour 
was diagnosed as clear cell carcinoma derived from an endometriosis focus. The long time interval – 17 years in 
average (from 3 to 39 years) between the surgery (cesarean section in most cases) and the tumor diagnosis is 
characteristic. In the case we describe, the patient was diagnosed 16 years after the endometriosis focus in the 
scar had arised. even though endometriosis is a benign lesion, it has many features distinctive for invasive carci-
noma; it may itself undergo a malignant transformation as well as increase the risk of endometrial carcinoma or 
clear cell ovarian carcinoma. Maybe in future, more exhaustive studies will allow establishing a therapeutic protocol 
in patients with extra-ovarian malignant transformation of endometriosis foci.
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Introduction
Endometriosis	 is	 defined	 as	 the	 occurrence	 of	 endometrial	
glands	 and	 endometrial	 stromal	 cells	 outside	 their	 typical	
localization	within	the	uterus	[1].	These	changes	are	most	often	
seen	in	ovaries	and	the	Pouch	of	Douglas.	Endometriosis	may	be	
classified	with	regard	to	its	anatomical	site	(surgical	staging	by	
the	revised	American	Fertility	Society	score)	or	on	the	basis	of	
histological	criteria	–	atypical	and	non-atypical	endometriosis	[2,	
3].	In	about	0.7%	–	1.0%	of	patients,	malignant	 transformation	
occurs.	 In	79%	of	cases,	 it	occurs	 in	ovaries,	 in	21%	–	 in	 foci	
outside	 ovaries	 [4].	Malignant	 transformation	 of	 endometriosis	
foci	 in	a	 scar	after	a	caesarean	section	 (cc)	 is	very	 rare	–	until	
2013	 (in	 a	 span	 of	 40	 years),	 about	 28	 such	 cases	 have	 been	
described.	 In	 our	 article,	 we	 describe	 a	 case	 of	 a	 42-year-old	
woman	with	a	tumour	localized	in	a	scar	after	a	caesarean	section.	
The	tumour	was	diagnosed	as	clear	cell	carcinoma	derived	from	
an	endometriosis	focus.
Case report
42-years	 old	 woman,	 was	 admitted	 to	 Gynecology	 and	
Obstetrics	 Ward	 in	 Merci	 Brother's	 in	 Katowice,	 due	 to	 two	
growing	tumors	in	a	scar	after	a	cesarean	section	that	she	had	17	
years	before;	 and	due	 to	 chronic	pain	during	 the	menstruation.	
A	surgical	excision	of	the	lesions	was	planned.	On	the	physical	
examination	 the	 tumors	 measured	 2x4	 cm	 (the	 tumor	 on	 the	
right	 side	 of	 the	 scar	 (in	 ultrasound	 examination:	 2x4cm),	 the	
tumor	on	the	left	side	of	the	scar	measured	2x5cm	(in	ultrasound	
examination:	2x6cm).	The	 transvaginal	ultrasound	examination	
showed	 uterus	 of	 homogenous	 echogenicity,	 measuring	
37.9	 mm	 in	 AP	 dimension.	 The	 endometrium	 was	 slightly	
heterohomogenous	18.8mm	thick,	 left	ovary	measured	39x18.7	
mm,	right	ovary	measured	34.4x24.4	mm,	there	was	insignificant	
amount	of	fluid	in	the	Douglas	cavity.
The	surgery	was	performed	with	Phannenstiel	incision.	The	
old	 scar	was	 excised,	 an	 endometrial	 tumor	measuring	 8x6cm	
was	dissected	from	the	subcutaneous	tissue.	Then,	a	similar	lesion	
was	dissected	from	the	fascia,	abdominal	recti	muscles,	parietal	
peritoneum	 and	 the	 area	 of	 pubic	 symphysis.	 The	 peritoneum	
cavity	was	opened,	any	endometrial	lesion	were	not	found.	The	
peritoneum	was	closed,	the	recti	muscles	were	approximated,	the	
fasca	was	repaired	with	a	prolene	mesh.	A	suction	drainage	was	
inserted.	The	skin	was	closed	with	continous	suture.	The	urine	in	
the	bladder	catheter	was	clear.	The	suction	drain	was	held	in	the	
wound	two	days.
The	 antibiotic	 prophylaxis	 was	 used.	 The	 wound	 healing	
was	normal.	The	patient	was	discharged	on	the	fifth	day	after	the	
surgery.
The	material	 obtained	 during	 the	 surgery	 –	more	 than	 ten	
irregular	 tissue	 fragments	 of	 total	 diameter	 of	 10	 cm	 –	 on	 the	
cross-section	 revealed	 fat	 tissue	 and	 grey,	 solid	 tissue	 with	
small,	 brown	 spots.	 The	material	 was	 referred	 for	 histological	
examination.	
Microscopic	 examination:	 the	 tumour	 consisted	 of	
pleomorphic	cells	with	clear	cytoplasm,	with	foci	of	glands	and	
nests.	The	 tumour	 infiltrated	 the	adjacent	 fat	 tissue.	The	nuclei	
varied	 from	 follicular	 to	 hyperchromatic;	 necrosis	 and	 atypical	
mitosis	figures	were	found.	In	the	staining	against	cytokeratin	7	
(CK7)	the	positive	reaction	was	obtained	in	the	carcinoma	cells,	
in	 the	 staining	 against	 cytokeratin	 20	 (CK	 20),	 the	 reaction	 in	
the	carcinoma	cells	was	negative.	The	Ki	67	antigen	was	found	
focally	in	20%	of	malignant	cells.
In	the	peripheral	parts	of	the	tumour,	foci	of	endometriosis	
with	 focal	 cellular	 atypia	 were	 found.	 To	 confirm	 that	 the	
observed	 foci	 are	 true	 endometriosis,	 ER	 and	CD-10	 stainings	
were	performed,	giving	a	positive	reaction.
After	 the	 surgery,	 in	April	 2013,	 performed	 in	 the	Cancer	
Centre	and	Institute	of	Oncology	in	Gliwice,	an	MR	was	carried	
out.	The	MR	examination	revealed	small	hypointensive	foci	under	
the	uterine	mucosa,	the	foci	were	enhanced	after	an	injection	of	
contrast	medium.	Two	new	foci	were	found	on	the	border	of	the	
cervix	and	body	of	the	uterus	and	in	the	fat	tissue	in	the	proximity	
of	the	cervix.	The	picture	of	endometrium	in	the	MR	examination	
was	unequivocal,	its	contour	was	uneven	and	faded.	The	abrasion	
of	 the	 uterine	 cavity	was	 carried	 out;	 in	 the	 abrasion	material,	
endometrial	polyps	were	found.	
In	 June	 2013,	 the	 radicalized	 surgery	 was	 performed:	
a	fragment	of	skin,	subcutaneous	tissue	and	fascia	were	excised.	
In	 an	 histological	 examination,	 no	 neoplastic	 foci	were	 found,	
only	 resorption	was	 seen.	At	 present,	 the	 patient	 is	 prescribed	
Visane.	The	PET	examination	did	not	reveal	any	neoplastic	foci.
 Streszczenie   
Endometrioza jest definiowana jako obecność gruczołów endometrialnych oraz komórek podścieliska poza typową 
lokalizacją w macicy. Złośliwa przemiana ognisk endometriozy w bliźnie po cięciu cesarskim jest bardzo rzadka- do 
roku 2013 (na przestrzeni ponad 40 lat) opisano około 20 takich przypadków. W naszej pracy opisujemy przypa-
dek 42-letniej kobiety z guzem zlokalizowanym w bliźnie po cięciu cesarskim, który został zdiagnozowany jako rak 
jasnokomórkowy wywodzący się z ogniska endometriozy. Zwraca uwagę długi interwał czasowy – średnio 17 lat 
(od 3-39 lat)  pomiędzy zabiegiem chirurgicznym (w większości cięciem cesarskim), a diagnozą zmiany nowotwo-
rowej. W opisywanym przez nas przypadku pacjentka została zdiagnozowana 16 lat po zaobserwowaniu ogniska 
endometriozy w bliźnie po cięciu. Pomimo iż endometrioza jest zmianą łagodną, posiada wiele charakterystycznych 
cech typowych dla raka inwazyjnego, może również sama przejść złośliwą transformację, jak i zwiększać ryzyko za-
chorowania na raka endometrioidalnego oraz jasnokomórkowego jajnika. Być może w przyszłości przeprowadzenie 
dokładnych badań pozwoli na ustalenie protokołu terapeutycznego u pacjentek, u których doszło do pozajajnikowej 
transformacji złośliwej ognisk endometriozy.
 Słowa kluczowe: endometrioza / blizna po cięciu cesarskim / złośliwa transformacja / 
                 / rak jasnokomórkowy / 
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Discussion
Endometriosis	is	a	problem	of	about	7-15%	of	women	at	the	
child-bearing	age	[1].	Endometriosis	in	a	caesarean	section	scar,	
known	as	iatrogenic	one,	was	first	described	in	1942	[5].	In	theory,	
it	can	arise	 in	every	 location	after	any	surgical	 intervention,	 its	
incidence	in	a	cc	scar	is	estimated	at	1%	[6].
In	 1925,	 Sampson	 first	 described	 the	 theory	 of	 retrograde	
menstruations	 requisite	 for	 the	 pathogenesis	 of	 endometriosis	
and	 its	malignant	 transformation	 into	ovarian	cancer	 [7,8].	The	
endometriosis	is	correlated	with	increased	risk	of	ovarian	cancer.	
The	 research	 of	 Brinton	 et	 al.	 revealed	 increased	 incidence	 of	
ovarian	cancer	 in	patients	with	endometriosis	 in	comparison	 to	
the	 general	 population	 [9].	This	 correlation	was	 found	 for	 two	
histological	types	of	cancer:	endometrial	and	clear	cell	carcinoma.	
Rossing	et	al.	reached	a	similar	conclusion:	after	investigating	
a	group	of	812	women	with	ovary	tumours,	they	found	that	the	
risk	of	endometrial	or	clear	cell	carcinoma	is	increased	3	times	in	
women	with	endometriosis	[10].	Modesit,	investigating	a	group	
of	 115	 cases	 of	 endometriosis	 coexisting	 with	 intra-peritoneal	
carcinomas,	found	that	the	most	frequent	were	endometrial	and	
clear	 cell	 carcinomas	 [11].	 Obviously,	 an	 ovarian	 carcinoma	
may	arise	directly	from	endometriosis	foci,	nonetheless	the	risk	
of	 ovarian	 carcinoma	 increases	 also	 when	 the	 endometriosis	
arises	outside	the	ovary.	In	a	population	of	women	with	ovarian	
carcinoma,	 endometriosis	 incidence	 reaches	 8-30%	 (two	 times	
more	than	in	the	healthy	women	population)	[1].
A	 strong	 correlation	 between	 endometriosis	 and	 ovarian	
carcinoma	may	be	explained	by	two	hypotheses:	endometriosis	
implants	 may	 undergo	 malignant	 transformation	 –	 through	
malignant	 endometriosis	 to	 cancer	 or/and	 both	 cancer	 and	
endometriosis	 have	 common	 antecedent	 mechanisms	 or	
predisposing	 factors.	 In	 a	 study	 presented	 by	Worley	 Jr.	 et	 al.,	
the	role	of	expression	of	some	transcriptional	factors	(like	HNF-
1β),	oxidative	stress,	some	cytokines	(TNF-α,	 IL-1β,	 IL-6)	and	
hyperestrogenism	in	the	development	of	endometriosis	as	well	as	
ovarian	cancer	are	demonstrated	[12].
Obviously,	both	these	hypotheses	do	not	exclude	each	other.
A	histological	 picture	of	 clear	 cell	 carcinoma	 in	our	 study	
consists	 of	 cuboidal	 and	 polygonal	 cells,	 containing	 abundant	
cytoplasm;	 the	 cytoplasm	 may	 be	 granular	 or	 eosinophilic.	
A	 distinguishing	 feature	 is	 “stab	 nail”	 cells,	which	may	 create	
sold	fields	or	cyst-like	spaces,	and	sometimes	they	build	tubular	
or	verrucous	structures.
The	 differential	 diagnosis	 should	 encompass:	 soft	
tissue	 tumours	 like	 desmoid,	 possible	 metastases	 to	 skin	 and	
subcutaneous	 tissue	 derived	 from	 clear	 cell	 kidney	 carcinoma,	
adrenal	 cortex	 carcinoma,	 melanoma,	 clear	 cell	 carcinoma	 of	
pancreas	or	epithelioid	variant	of	leiomyosarcoma.
Tumours	derived	from	the	genital	tract	are	CK7(+),	p53(+)	
and	 CK20(-),	 clear	 cell	 kidney	 carcinoma	 is	 PAX-8,	 HNF-1β,	
RCC,	 EMA	 and	 CD-10	 positive.	 Melanoma	 shows	 positive	
response	 with	 S-100	 and	 HMB-45,	 adrenal	 cortex	 carcinoma	
is	 positive	 in	 staining	 against	 S-100	 and	 inhibin.	 Clear	 cell	
carcinoma	derived	from	pancreas	shows	positive	reaction	against	
CK7,	CK18,	CEA,	HNF-1β,	and,	in	50%	of	cases,	against	CK20.	
The	epithelioid	variant	of	leiomyosarcoma	is	SMA	positive	[12].
Up	 till	 now,	 there	 have	 been	 about	 20	 cases	 of	malignant	
transformation of endometriosis into clear cell carcinoma in 
a	cc	scar	described	in	the	literature.	In	most	cases,	after	a	radical	
 
Figure 1. Foci of the clear cell carcinoma (hematoxilin-eosin staining).
 
Figure 2. Foci of the clear cell carcinoma- left side and atypical endometriosis- 
right side (hematoxilin-eosin staining).
 
Figure 3. Foci of the clear cell carcinoma (CK-7 staining).
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resection	 of	 the	 tumour,	 adjuvant	 chemotherapy	 or	 adjuvant	
radiotherapy	were	applied.	Only	in	few	cases,	a	resection	of	the	
tumour,	 followed	 by	 hysterectomy	 were	 carried	 out	 [13].	 Our	
patient	did	not	have	any	 symptoms	 for	30	months.	Among	 the	
remaining	 patients,	 of	 whom	 the	 follow-up	 was	 available	 (11	
women),	 6	 died	 during	 20	 months,	 which	 makes	 as	 much	 as	
40%	[13-20].	Because	of	the	rarity	of	these	tumours,	the	optimal	
therapeutic	options	have	not	been	established	[21].
Summarising,	 even	 though	 endometriosis	 is	 a	 benign	
lesion,	 it	 has	many	 features	distinctive	 for	 invasive	carcinoma;	
it	 may	 itself	 undergo	 a	 malignant	 transformation	 as	 well	 as	
increase	the	risk	of	endometrial	carcinoma	or	clear	cell	ovarian	
carcinoma.	 Obviously,	 preventing	 endometriosis	 is	 impossible	
and	 pharmacotherapy	 is	 often	 ineffective,	 nonetheless,	 with	
regard	 to	 its	 high	 incidence	 (endometriosis	 occurs	 in	 more	
than	10%	of	women	 at	 the	 child-bearing	 age	 and	 in	 about	 3%	
of	post-menopausal	women),	 in	 the	group	of	patients	 in	whom	
endometriosis	 is	 diagnosed,	 hormonal	 replacement	 therapy	
should	not	be	implemented	because	of	increased	risk	of	ovarian	
carcinoma	and	malignant	transformation.
Maybe	 in	 future,	 more	 exhaustive	 studies	 will	 allow	
establishing	a	therapeutic	protocol	in	patients	with	extra-ovarian	
malignant	transformation	of	endometriosis	foci.
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